COVID-19 pandemic is still affecting many countries, especially the United Kingdom, where a new variant of the deadly virus was discovered. Many medical experts suggested that the country needs to have better methods or ways of administering the COVID-19 vaccines to the public.
According to Independent UK's latest report, a former vaccine chief provide new ways on how to administer the medicines quicker and more efficiently. She said that the country needs new methods such as patches, nasal sprays, or pills to speed up the process.
Kate Bingham said that the U.K. and E.U. need to collaborate during the ongoing pandemic and develop new vaccines against the new COVID-19 variants that are surfacing.
New COVID-19 vaccine introduced in the UK
She further explained that she also welcomed the results of trial data from the United States Company Novavax. This new vaccine was revealed on Thursday, Jan. 28. BBC reported that the vaccine developers revealed that the new medicine has an efficacy of 89%.
AURORA, CO - DECEMBER 15: (EDITORIAL USE ONLY) Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech holds a dose of the Johnson & Johnson COVID-19 vaccine before it is administered in a clinical trial on December 15, 2020 in Aurora, Colorado. The Johnson & Johnson vaccine could be submitted for emergency use by late January and is the only vaccine among leading candidates given as a single dose.
The former vaccine chief confirmed that Novavax will shortly submit data to the Medicines and Healthcare products Regulatory Agency (MHRA) for approval.
"We for sure need to be working together [with EU] to develop those tweaked vaccines that will address the new variants, which will inevitably arise because that's what viruses do is they mutate, and we need to improve the vaccine format," she said via Independent UK.
She added that delivering two injections is not a good way of administering vaccines. The health expert added that the country needs to get vaccine formats that are much more distributable and scalable.
UK's early vaccination program
Bingham reiterated that the country got ahead in its vaccination supply since it began production earlier than expected. She said that AstraZeneca's CEO didn't mention that the United Kingdom began scaling up the manufacture of the Oxford vaccine from February last year of 2020. She said that the scaling up was voluntary and wasn't based on any contract or agreement.
For more news updates about COVID-19 vaccines and the ongoing pandemic, always keep your tabs open here at TechTimes.
Related Article: COVID-19 Can Cause Sperm Damage, Infertility, Study Says
This article is owned by TechTimes.
Written by: Giuliano de Leon.
